|
|
Volumn 28, Issue 2, 2008, Pages 114-119
|
|
Drug-eluting stents: Insights into safety and indications
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
PACLITAXEL;
POLYMER;
RAPAMYCIN;
THIENOPYRIDINE DERIVATIVE;
ARTERY GRAFT;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY OBSTRUCTION;
CORONARY ARTERY RECANALIZATION;
CORONARY STENT;
DATA ANALYSIS;
DRUG COATING;
DRUG ELUTING STENT;
DRUG INDICATION;
DRUG SAFETY;
DRUG WITHDRAWAL;
GRAFT PATENCY;
HEART INFARCTION;
HUMAN;
IN-STENT RESTENOSIS;
INTERNAL MAMMARY ARTERY;
MATERIAL COATING;
MONOTHERAPY;
MORTALITY;
PATIENT SELECTION;
PRIORITY JOURNAL;
RADIAL ARTERY;
REGISTER;
REOPERATION;
REVIEW;
RISK BENEFIT ANALYSIS;
SAPHENOUS VEIN GRAFT;
THROMBOSIS;
|
|
EID: 43149106738
PISSN: 02564947
EISSN: 13199226
Source Type: Journal
DOI: 10.5144/0256-4947.2008.114 Document Type: Review |
|
Times cited : (1)
|
|
References (35)
|
